TargeGen's Acquisition

TargeGen was acquired by Sanofi on June 30, 2010.

TargeGen, a vascular biology-focused biopharmaceutical company, discovers and develops small molecule kinase inhibitors that target vascular leakage, vascular proliferation, and inflammation.…

Articles about TargeGen's Acquisition: